Key result
Hepatic lipase modulates lipoprotein metabolism and atherosclerosis development through alternative mechanisms, including serving as a ligand for cell surface receptors.
This review highlights alternative mechanisms by which hepatic lipase modulates lipoprotein metabolism and atherosclerosis development.
Answers are grounded in this paper and cite their sources.
May modulate lesions in models; leaves open whether hepatic lipase targeting alters human atherosclerosis.
In addition to its traditional role in the hydrolysis of lipoprotein triglycerides and phospholipids, recent studies have implicated hepatic lipase in other aspects of cellular lipid and/or lipoprotein metabolism and atherosclerosis. Hepatic lipase may serve as a ligand that mediates the interaction of lipoproteins to cell surface receptors and/or proteoglycans as well as modulating aortic lesion development in different animal models. Over the past several years significant advances have been made in our understanding of new, alternative mechanisms by which hepatic lipase may modulate lipoprotein metabolism and the development of atherosclerosis in vivo.
No takes yet. Share an insight, caveat, or question.
Santamarina-Fojo et al. (1998) conducted a review in Atherosclerosis and lipoprotein metabolism. Hepatic lipase was evaluated. Hepatic lipase modulates lipoprotein metabolism and atherosclerosis development through alternative mechanisms, including serving as a ligand for cell surface receptors.
Synapse has enriched 10 related papers. Consider them for comparative context: